APA (7th ed.) Citation

Cuzzubbo, S., Ursu, R., Mazoyer, J., Belin, C., Baroudjian, B., Lebbe, C., & Carpentier, A. (2018). P05.76 Resuming treatment with immune checkpoint inhibitors in cancer patients who developed immune-related meningitis. Neuro-oncology, 20, iii321. https://doi.org/10.1093/neuonc/noy139.402

Chicago Style (17th ed.) Citation

Cuzzubbo, S., R. Ursu, J. Mazoyer, C. Belin, B. Baroudjian, C. Lebbe, and A. Carpentier. "P05.76 Resuming Treatment with Immune Checkpoint Inhibitors in Cancer Patients Who Developed Immune-related Meningitis." Neuro-oncology 20 (2018): iii321. https://doi.org/10.1093/neuonc/noy139.402.

MLA (9th ed.) Citation

Cuzzubbo, S., et al. "P05.76 Resuming Treatment with Immune Checkpoint Inhibitors in Cancer Patients Who Developed Immune-related Meningitis." Neuro-oncology, vol. 20, 2018, p. iii321, https://doi.org/10.1093/neuonc/noy139.402.